Skip to main content
SpringerLink
Log in

Crossreacting drugs and chemicals

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Aspirin and nonsteroidal antiinflammatory drugs (NSAIDs) exert their clinical effect through inhibition of prostaglandin H synthases 1 and 2, also known as cyclooxygenase. This shared effect of COX-inhibition is also the mechanism for shared adverse effects. Much of our understanding of cross-reacting drugs and chemicals with aspirin comes from studying asthmatics with aspirin-exacerbated respiratory disease (AERD). Aspirin exacerbated respiratory disease is characterized by recalcitrant sinusitis/polyposis, asthma and precipitation of asthma after ingestion of aspirin and most NSAIDs. Cross-reactions between ASA and NSAIDs occur with first exposure unlike IgE-mediated allergic drug reactions. Cross-reactions between aspirin and other drugs are dependent upon inhibition of the cyclooxygenase-1 isoenzyme. Desensitization to aspirin will result in cross-desensitization to all NSATDs that inhibit COX-1. Despite reports in the literature, there does not appear to he cross-reactions between food coloring, hydrocortisone succinate and monosodium glutamate in individuals with aspirin exacerbated respiratory disease. The new highly selective cyclooxygenase 2 inhibitors are well tolerated in AERD asthmatics who have not been desensitized to aspirin. Because low-dose ASA exerts a cardioprotective effect by irreversible inhibition of COX-1, AERD patients who are at risk for coronary artery disease should be considered for aspirin desensitization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hamberg, M., Svensson, J., and Samuelsson, B. (1974), Novel transformation of arachidonic acid in human platelets. Proc. Natl. Acad. Sci. USA 71, 3400–3404.

    Article  PubMed  CAS  Google Scholar 

  2. Stevenson, D. D. and Simon R. A. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs, in: Allergy: Principles and Practice, Middleton, R. C. W., and Busse, W. W., eds., 5th ed. Mosby St. Louis, 1998, pp. 1225–1234.

    Google Scholar 

  3. Vane, J. R., Bakhle, Y. S., and Botting, R. M. (1998). Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38, 91–120.

    Article  Google Scholar 

  4. Kraemer, S. A., Meade, C. A., and DeWitt, D. L. (1992), Prostaglandin endoperoxidase synthase gene structure: identification of the transcriptional start site and 5' flanking regulatory sequences. Arch. Biochem. Biophys. 293, 391–400.

    Article  PubMed  CAS  Google Scholar 

  5. Hinz, B., and Brune, K. (2002), Cyclooxygenase-2–10 years later. J. Pharmacol. Exp. Ther. 300, 357–375.

    Article  Google Scholar 

  6. Berg, D. J., Zhang, J., Lauricella, D. M., and Moore, S. A. (2001), IL-10 is a central regulator of cyclo-oxygenase-2 expression and prostaglandin production. J. Immunol. 166, 2674–2680.

    PubMed  CAS  Google Scholar 

  7. Gierse, J. K., Hauser, S. D., Creely, D. P., Koboldt, C., Rangwala, S. H., Isakson, P. C., et al. (1993) Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem. J. 305 (Pt 2) 479–484.

    Google Scholar 

  8. Picot, D., Loll, P. J., and Garavito, R. M. (1994), The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature 367, 243–249.

    Article  PubMed  CAS  Google Scholar 

  9. Picot, D., Loll, P. J., and Garavito, R. M. (1997), X-ray crystallographic study of the structure of prostaglandin H synthase. Adv. Exp. Med. Biol. 400A, 107–111.

    PubMed  CAS  Google Scholar 

  10. Roth, G. J., Stanford, N., and Majerus, P. W. (1975). Acetylation of prostaglandin synthase by aspirin. Proc. Natl. Acad. Sci. USA 72, 3073–3076.

    Article  PubMed  CAS  Google Scholar 

  11. Luong, C., Miller, M., Barnett, J., Chow, J., Ramesha, C., and Browner, M. F. (1996), Flexibility of NSAID binding site in the structure of human cyclooxygenase 2 Nat. Struct. Biol. 3, 927–933.

    Article  PubMed  CAS  Google Scholar 

  12. Kurambail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., et al. (1996), Structural basis for selective inhibition of cyclooxygenase-2 by antiinflammatory agents. Nature 384, 644–648.

    Article  Google Scholar 

  13. Stevenson, D. D. (1984), Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal antiinflammatory drugs. J. Allergy Clin. Immunol. 74, 617–622.

    Article  PubMed  CAS  Google Scholar 

  14. Funk, C. D. (2001), Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871–1875.

    Article  PubMed  CAS  Google Scholar 

  15. Demoly, P., Jaffuel, D., Lequeux, N., Weksler, B., Creminon, C. H., Michel, F.-B., et al. (1997), Prostaglandin H synthase 1 and 2 immunoreactivities in the bronchial mucosa of asthmatics. Am. J. Respir. Crit. Care Med. 155, 670–675.

    PubMed  CAS  Google Scholar 

  16. Szczeklik, A., and Stevenson, D. D. (1999), Aspirin-induced asthma: advances in pathogenesis and management. J. Allergy Clin. Immunol. 104, 5–13.

    Article  PubMed  CAS  Google Scholar 

  17. Szczeklik, A. (1990), The cylcooxygenase theory of aspirin-induced asthma. Eur. Respir. J. 3, 588–593.

    PubMed  CAS  Google Scholar 

  18. Fischer, A. R., Rosenberg, M. A., Lilly, C. M., Callergy, J. C., Rubin, P., Cohn, J., et al. (1994), Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J. Allergy Clin. Immunol. 94, 1046–1056.

    Article  PubMed  CAS  Google Scholar 

  19. Vanselow, N. A., and Smith, J. R. (1967), Bronchial asthma induced by indomethacin. Ann. Intern. Med. 66, 568–573.

    PubMed  CAS  Google Scholar 

  20. Samter, M. and Beers, R. J. (1968), Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann. Intern. Med. 68, 975–983.

    PubMed  CAS  Google Scholar 

  21. Szczeklik, A., Gryglewski, R. J., and Czerniawska-Mysik, G. (1977), Clinical patterns of hypersensitivity to nonsteroidal antiinflammatory drugs and their pathogenesis. J. Allergy Clin. Immunol. 60, 276–284.

    Article  PubMed  CAS  Google Scholar 

  22. Szczeklik, A. and Gryglewski, R. J. (1983), Asthma and antiinflammatory drugs: mechanisms and clinical patterns. Drugs 25, 533–543.

    PubMed  CAS  Google Scholar 

  23. Mathison, D. A., and Stevenson, D. D. (1979), Hypersensitivity to nonsteroidal antiinflammatory drugs: indications and methods for oral challenges. J. Allergy Clin. Immunol. 64, 669–674.

    Article  PubMed  CAS  Google Scholar 

  24. Stevenson, D. D., Hougham, A., Schrank, P., and Goldlust, M. B. (1990), Disalcid cross-sensitivity in aspirin-sensitive asthmatic patients. J. Allergy Clin. Immunol. 86, 749–758.

    Article  PubMed  CAS  Google Scholar 

  25. Sheehan, G. J., Kutzner, M. R., and Chin, W. D. (1989), Acute asthma attack due to ophthalmic indomethacin. Ann. Intern. Med. 11, 337–338.

    Google Scholar 

  26. Stevenson, D. D. (1986), Aspirin desensitization. N. Engl. Reg. Allergy Proc. 7, 101–104.

    Article  PubMed  CAS  Google Scholar 

  27. Stevenson, D. D. (1987), Aspirin sensitivity: new approaches to detection and desensitization. Int. Med. Spec. 8, 60–68.

    Google Scholar 

  28. Pleskow, W. W., Stevenson D. D., Mathison, D. A., Simon, R. A., Schatz, M., and Zeiger, R. S. (1982), Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J. Allergy Clin. Immunol. 69, 11–19.

    Article  PubMed  CAS  Google Scholar 

  29. Bosso, J. V., Creighton, D., and Stevenson, D. D. (1992), Fluriprofen (Ansaid) cross-sensitivity in an aspirin-sensitive asthmatic patient. Chest 101, 856–858.

    PubMed  CAS  Google Scholar 

  30. Szmidt, M., Grzelewska-Rzymowska, I., and Rozniecki, J. (1993), Tolerance to aspirin in aspirin-sensitive asthmatics. Methods of inducing the tolerance state and its influence on the course of asthma and rhinosinusitis. J. Investig. Allergol. Clin. Immunol. 3, 156–159.

    PubMed  CAS  Google Scholar 

  31. Szmidt, M., Grzelewska-Rzymowska, I., Kowalski, M., et al. (1987) Tolerance to acetylsalicylic acid (ASA) induced in ASA-sensitive asthmatics does not depend on initial adverse reaction. Allergy 42, 182–185.

    Article  PubMed  CAS  Google Scholar 

  32. Falliers, C. J. (1983), Acetaminophen and aspirin challenges in subgroups of asthmatics. J. Asthma 20 (Suppl 1), 39–49.

    PubMed  Google Scholar 

  33. Schwarz, N., and Ham Pong, A. (1996), Acetaminophen anaphylaxis with aspirin and sodium salicylate sensitivity: a case report. Ann. Allergy Asthma Immunol. 77, 473–474.

    PubMed  CAS  Google Scholar 

  34. Settipane, R. A. and Stevenson, D. D. (1989), Cross sensitivity with acetaminophen in aspirinsensitive subjects with asthma. J. Allergy Clin. Immunol. 84, 26–33.

    Article  PubMed  CAS  Google Scholar 

  35. Settipane, R. A., Schrank, P. J., Simon, R. A., Mathison, D. A., Christiansen, S. C., and Stevenson, D. D. (1995), Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J. Allergy Clin. Immunol. 96, 480–485.

    Article  PubMed  CAS  Google Scholar 

  36. Delaney, J. C. (1976) The diagnosis of aspirin idiosyncrasy by analgesic challenge. Clin. Allergy 6, 177–181.

    Article  PubMed  CAS  Google Scholar 

  37. Andri, L., Senna, G., Betteli, C., Givanni, S., Scaricabarozzi, I., Mezzelani, P., et al. (1994), Tolerability of nimesulide in aspirin-sensitive patients. Ann. Allergy 72, 29–32.

    PubMed  CAS  Google Scholar 

  38. Asero, R. (1998), Aspirin and paracetamol tolerance in patients with nimesulide-induced urticaria. Ann. Allergy Asthma Immunol. 81, 237–238.

    PubMed  CAS  Google Scholar 

  39. Bavbek, S., Celik, G., Ediger, D., Mungan, D., Demirel, Y. S., and Misirligil, Z. (1999), The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal antiinflammatory drug intolerance. J. Asthma 36, 657–663.

    PubMed  CAS  Google Scholar 

  40. Quaratino, D., Romano, A., Di Fonso, M., Papa, G., Perrone, M. R., D’Ambrosio, F. P. et al. (2000), Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal antiinflammatory drugs.—Ann. Allergy Asthma Immunol. 84, 613–617.

    PubMed  CAS  Google Scholar 

  41. Kosnik, M., Music, E., Matjaz, F., and Suskovic, S. (1998), Relative safety of meloxicam in NSAID-intolerant patients. Allergy 53, 1231–1233.

    Article  PubMed  CAS  Google Scholar 

  42. Szczeklik, A., Nizankowska, E., Bochenek, G., Nagraba, K., Mejza, F., and Swiercznska, M. (2001), Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin. Exp. Allergy 31, 219–225.

    Article  PubMed  CAS  Google Scholar 

  43. Stevenson, D. D., and Simon, R. A. (2001), Lack of crossreactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J. Allergy Clin. Immunol. 108, 47–51.

    Article  PubMed  CAS  Google Scholar 

  44. Yoshida, S., Ishizaki, Y., Onuma, K., Shoji, T., Nakagawa, H., and Amayasu, H. (2000), Selective cyclo-oxygenase 2 inhibitor in patients with asthma and aspirin intolerance [letter]. J. Allergy Clin. Immunol. 106, 1203–1204.

    Article  Google Scholar 

  45. Dahlen, B., Szczeklik, A., and Murray, J. J. (2001), Celecoxib in patients with asthma and aspirin intolerance [letter]. N. Engl. J. Med. 344, 142.

    Article  PubMed  CAS  Google Scholar 

  46. Woessner, K. M., and Simon, R. A. (2002), The safety of celecoxib in patients with aspirin sensitive asthma. Arthritis Rheum. 46, 2201–2206.

    Article  PubMed  CAS  Google Scholar 

  47. Physicians Desk Reference, 55th ed. Medical Economics Company, Montvale, NJ, 2001, pp. 2213–2676.

  48. Levy, M. B., and Fink, J. N. (2001), Anaphylaxis to celecoxib. Ann. Allergy Asthma Immunol. 87, 72–73.

    Article  PubMed  CAS  Google Scholar 

  49. Schellenberg, R. R., ISH, (2001), Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor. N. Engl. J. Med. 345, 1856.

    Article  PubMed  CAS  Google Scholar 

  50. Spector, S. L., Wangaard, C. H., and Farr, D. S. (1979), Aspirin and concomitant idiosyncrasies in adult asthmatic patients. J. Allergy Clin. Immunol. 64, 500–506.

    Article  PubMed  CAS  Google Scholar 

  51. Freedman, B. (1977), Asthma induced by sulfur dioxide, benzoate and tartrazine contained in orange drinks. Clin. Allergy 7, 407–411.

    Article  PubMed  CAS  Google Scholar 

  52. Juhlin, L., Michaelsson, G., and Zetterstrom, O. (1972), Urticaria and asthma induced by food and drug additives in patients with aspirin sensitivity. J. Allergy Clin. Immunol. 50, 92–102.

    Article  PubMed  CAS  Google Scholar 

  53. Allen, D. H., Delohery, J., and Baker, G. (1987), Monosodium L-glutamate-induced asthma. J. Allergy Clin. Immunol. 80, 530–537.

    Article  PubMed  CAS  Google Scholar 

  54. Weber, R. W., Hoffman, M., Raine, D. A., Jr., and Nelson, H. S. (1979), Incidence of bronchocon-striction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics. J. Allergy Clin. Immunol. 64, 32–37.

    Article  PubMed  CAS  Google Scholar 

  55. Ardern, K. D. and Ram, F. S. (2001), Tartrazine exclusion for allergic asthma (Cochrane Review). Cochrane Database Syst. Rev. 4, CD000460.

    Google Scholar 

  56. Stevenson, D. D., Simon, R. A., Lumry, W. R., and Mathison, D. A. (1986), Adverse reactions to tartrazine. J. Allergy Clin. Immunol. 78, 182–191.

    Article  PubMed  CAS  Google Scholar 

  57. Szczeklik, A., Nizankowska, E., and Sanak, M. (1998), New insights into the pathogenesis and management of aspirin-induced asthma. Clin. Asthma Reviews 2, 79–86.

    Google Scholar 

  58. Dajani, B. M., Sliman, N. A., and Shubair, K. S. (1981), Bronchospasm caused by intravenous hydrocortisone succinate (Solu-Cortef) in aspirinsensitive asthmatics. J. Allergy Clin. Immunol. 68, 201–204.

    Article  PubMed  CAS  Google Scholar 

  59. Szczeklik, A., Nizankowska, E., Czerniawska-Mysik, G., and Sek, S. (1985)) Hydrocortisone and airflow impairment in aspirin-induced asthma. J. Allergy Clin. Immunol. 76, 530–536.

    Article  PubMed  CAS  Google Scholar 

  60. Feigenbaum, B. A., Stevenson, D. D., and Simon, R. A. (1995), Lack of cross-sensitivity to IV hydrocortisone in aspirin-sensitive subjects with asthma. J. Allergy Clin. Immunol., 96, 545–548.

    Article  PubMed  CAS  Google Scholar 

  61. Moneret-Vautrin, D. A. (1987), Monosodium glutamate induced asthma: study of the potential risk in 30 asthmatics and a review of the literature. Alergie et Immunol. 19, 29–35.

    CAS  Google Scholar 

  62. Stevenson, D. D. (2000), Monosodium glutamate and asthma. J. Nutrition 130, 1067–1073.

    Google Scholar 

  63. Schwartzstein, R., Kelleher, M., Weingerger, S. E., Weiss, J. W., and Drazen, J. M. (1987), Airway effects of monosodium glutamate in subjects with chronic stable asthma. J. Asthma 24, 167–172.

    PubMed  CAS  Google Scholar 

  64. Germano, P., Cohen, S. G., Hahn, B., and Metcalfe, D. D. (1991), An evaluation of clinical reactions to monosodium glutamate (MSG) in asthmatics, using a blinded placebo-controlled challenge. J. Allergy. Clin. Immunol. 87, 177.

    Article  Google Scholar 

  65. Woods, R., Weiner, J., Thien, F., Abramson, M., and Walters, E. (1998), The effects of monosodium glutamate in adults with asthma who perceive themselves to be monosodium glutamate-intolerant. J. Allergy Clin. Immunol. 101, 762–771.

    Article  PubMed  CAS  Google Scholar 

  66. Woessner, K. M., Simon, R. A., and Stevenson, D. D. (1999), Monosodium glutamate sensitivity in asthma. J. Allergy Clin. Immunol. 104, 305–310.

    Article  PubMed  CAS  Google Scholar 

  67. Stevenson, D. D., and Simon, R. A. (1981), Sensitivity to ingested metabisulfite in asthmatic subjects. J. Allergy Clin. Immunol. 68, 26–20.

    Article  PubMed  CAS  Google Scholar 

  68. Szczeklik, A., Nizankowska, E., and Dworski, R. (1990), Choline magnesium trisalicylate in patients with aspirin-induced asthma. Eur. Respir. J. 3, 535–539.

    PubMed  CAS  Google Scholar 

  69. Patrono, C. (2001), Efficacy and safety of aspirin in the long-term management of atherothrombosis. Haematologica 86, 19–21.

    PubMed  CAS  Google Scholar 

  70. Patrono, C., Patrignani P., and Garcia Rodriguez, L. A. (2001), Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J. Clin. Investig. 108, 7–13.

    Article  PubMed  CAS  Google Scholar 

  71. Schaefer, O. P., and Gore, J. M. (1999), Aspirin sensitivity: the role for aspirin challenge and desensitization in postmyocardial infarction patients. Cardiology 91, 8–13.

    Article  PubMed  CAS  Google Scholar 

  72. Parks, W. M., Hoak, J. C., and Czervionke, R. L. (1981), Comparative effect of ibuprofen on endothelial and platelet prostaglandin synthesis. J. Pharmacol Exp. Ther. 219, 415–419.

    PubMed  CAS  Google Scholar 

  73. Rao, G. H., Johnson, G. G., Reddy, K. R., and White, J. G. (1983), Ibuprofen protects platelet cyclo-oxygenase from irreversible inhibition by aspirin. Arteriosclerosis 3, 383–388.

    PubMed  CAS  Google Scholar 

  74. Cerletti, C. (1985), Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity. Int. J. Tissue React. 7, 309–312.

    PubMed  CAS  Google Scholar 

  75. Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., et al. (2001), Cyclooxygenase inhibitors and the anti-platelet effects of aspirin. N. Engl. J. Med. 345, 1809–1817.

    Article  PubMed  CAS  Google Scholar 

  76. Copeland, R. A., Williams, J. M., Giannaras, J., Nurnberg, S., Covington, M., Pinto, D., et al. (1994), Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc. Natl. Acad. Sci. USA 91, 11,202–11,206.

    Article  CAS  Google Scholar 

  77. Ouellet, M., and Percival, M. D. (1995), Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms. Biochem. J. 306 (Pt 1), 247–251.

    PubMed  Google Scholar 

  78. Reilly, I. A., and FitzGerald, G. A. (1987), Blood 69, 180–186.

    PubMed  CAS  Google Scholar 

  79. Ouellet, M., Riendeau, D., and Percival, M. D. (2001), A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin. Proc. Natl. Acad. Sci. USA 98, 14,583–14,588.

    Article  CAS  Google Scholar 

  80. Greenberg, H. E., Gottesdiener, K., Huntington, M. Wong, P., Larson, P., Wildonger, L., et al. (2000), A new cyclooxygenase-2 inhibitor rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers. J. Clin. Pharmacol. 40, 1509–1515.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Scripps Clinic Medical Group, 10666 North Torrey Pines Rd., 92037, La Jolla, CA

    Katharine M. Woessner

Authors
  1. Katharine M. Woessner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Woessner, K.M. Crossreacting drugs and chemicals. Clinic Rev Allerg Immunol 24, 149–158 (2003). https://doi.org/10.1385/CRIAI:24:2:149

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/CRIAI:24:2:149

Index Entries

Search

Navigation